Asia Pacific Small Molecule Drug Discovery Market Forecast to 2027 - By Size, Share, Growth by End User and Forecast| Business Market Insights

1. Introduction

1.1 Business Market Insights Research Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:

4. Asia Pacific Small Molecule Drug Discovery Market Landscape

4.1 Market Overview

4.2 Porter's Five Forces Analysis

4.2.1 Bargaining Power of Suppliers
4.2.2 Bargaining Power of Buyers
4.2.3 Threat of New Entrants
4.2.4 Competitive Rivalry
4.2.5 Threat of Substitutes

4.3 Ecosystem Analysis

4.3.1 Raw Material Suppliers
4.3.2 Manufacturers
4.3.3 Distributors/Suppliers
4.3.4 End Users

5. Asia Pacific Small Molecule Drug Discovery Market – Key Market Dynamics

5.1 Growth Drivers

5.1.1 Flourishing Pharmaceutical Industry

5.2 Market Opportunities

5.2.1 Increasing Small Molecule-Based Pipeline

5.3 Future Trends

5.3.1 Growing adoption of artificial intelligence in drug discovery

5.4 Impact of Drivers and Restraints

6. Asia Pacific Small Molecule Drug Discovery Market Regional Analysis

6.1 Asia Pacific Small Molecule Drug Discovery Market Overview

6.2 Asia Pacific Small Molecule Drug Discovery Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Small Molecule Drug Discovery Market Forecast Analysis

7. Asia Pacific Small Molecule Drug Discovery Market Analysis – by Therapeutic Area

7.1 Oncology

7.1.1 Overview
7.1.2 Oncology: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.2 Central Nervous System

7.2.1 Overview
7.2.2 Central Nervous System: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.3 Cardiovascular

7.3.1 Overview
7.3.2 Cardiovascular: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.4 Respiratory

7.4.1 Overview
7.4.2 Respiratory: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.5 Orthopedics

7.5.1 Overview
7.5.2 Orthopedics: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.6 Immunology

7.6.1 Overview
7.6.2 Immunology: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.7 Rare Diseases

7.7.1 Overview
7.7.2 Rare Diseases: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

7.8 Other Therapeutic Areas

7.8.1 Overview
7.8.2 Other Therapeutic Areas: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2031 (US$ Million)

8. Asia Pacific Small Molecule Drug Discovery Market Analysis – by Process/Phase

8.1 Target Discovery

8.1.1 Overview
8.1.2 Target Discovery: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.2 Target Validation

8.2.1 Overview
8.2.2 Target Validation: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.3 Lead Generation and Refinement

8.3.1 Overview
8.3.2 Lead Generation and Refinement: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Preclinical Development

8.4.1 Overview
8.4.2 Preclinical Development: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

9. Asia Pacific Small Molecule Drug Discovery Market – Asia-Pacific Analysis

9.1 Asia-Pacific

9.1.1 Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Key Country, 2020 and 2027 (%)
9.1.1.1 Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast Analysis – by Country
9.1.1.1 China: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.1.1 China: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
9.1.1.1.2 China: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase

9.1.1.2 India: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.2.1 India: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
9.1.1.2.2 India: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase

9.1.1.3 Japan: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.3.1 Japan: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
9.1.1.3.2 Japan: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase

9.1.1.4 Australia: Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.4.1 Australia: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
9.1.1.4.2 Australia: Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase

9.1.1.5 Rest of Asia-Pacific : Asia Pacific Small Molecule Drug Discovery Market – Revenue and Forecast to 2027 (US$ Million)

9.1.1.5.1 Rest of Asia-Pacific : Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Therapeutic Area
9.1.1.5.2 Rest of Asia-Pacific : Asia Pacific Small Molecule Drug Discovery Market Breakdown, by Process/Phase

10. Competitive Landscape

10.1 Heat Map Analysis

10.2 Company Positioning and Concentration

11. Asia Pacific Small Molecule Drug Discovery Market Industry Landscape

11.1 Overview

11.2 Mergers and Acquisitions

11.3 Agreements, Collaborations, and Joint Ventures

11.4 New Product Launches

11.5 Expansions and Other Strategic Developments

12. Company Profiles

12.1 Pfizer Inc

12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments

12.2 GlaxoSmithKline plc

12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments

12.3 Johnson & Johnson Services, Inc

12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments

12.4 Gilead Sciences, Inc

12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments

12.5 Teva Pharmaceutical Industries Ltd

12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments

13. Appendix

13.1 About Business Market Insights